![]() |
|
|
Gladstone Institute of Cardiovascular Disease, Division of Endocrinology and Department of Medicine, University of California, San Francisco, CA 94141
| ABSTRACT |
|---|
|
|
|---|
KEY WORDS: sterols intestinal absorption nuclear hormone receptors ABC transporters sitosterolemia cholesterol esters
| INTRODUCTION |
|---|
|
|
|---|
|
| Regulation of Sterol Absorption by Nuclear Hormone Receptors. |
|---|
|
|
|---|
Two nuclear hormone receptors involved in the regulation of cholesterol
homeostasis are the liver X receptor (LXR) and the farnesoid X receptor
(FXR). The natural ligands for LXR and FXR are oxysterols
(oxidized derivatives of cholesterol) and bile acids, respectively
[reviewed in (2
4)
]. To modulate transcriptional
activity, ligand-activated LXR or FXR forms a heterodimer with one
additional nuclear hormone receptor, the retinoid X receptor (RXR).
These heterodimers then control the transcription of several important
genes that participate in cholesterol metabolism, sometimes appearing
to antagonize the effects of each other. For example, the LXR-RXR
heterodimer induces the expression of cholesterol 7
-hydroxylase
(CYP7A1), the rate-limiting enzyme in the classic bile acid
synthesis pathway (2
,3)
. In contrast, the FXR-RXR
heterodimer represses CYP7A1 transcription (5)
. It was
unclear how the activation of both heterodimers would affect
cholesterol metabolism in an animal model.
Because both the LXR-RXR and the FXR-RXR heterodimers can
be activated by RXR ligands, Mangelsdorf and colleagues
(6)
administered an RXR ligand, the rexinoid LG268, to
mice to identify LXR-RXR and FXR-RXRmediated changes in cholesterol
homeostasis. Administration of the ligand resulted in a
dose-dependent inhibition of cholesterol absorption. Two mechanisms
were involved in this reduction in cholesterol absorption. In one
mechanism, the FXR-RXR heterodimer suppressed CYP7A1 expression and
decreased bile acid synthesis. Because nonpolar lipids such as
cholesterol have a limited solubility in the aqueous environment of the
intestinal lumen, bile acids are required to solubilize these nonpolar
compounds and allow their absorption. By suppressing bile acid
production, the activated FXR-RXR heterodimer decreased the
solubilization and absorption of dietary cholesterol.
Even though activation of the LXR-RXR heterodimer could not counter the FXR-RXRmediated suppression of CYP7A1 expression, the activated LXR-RXR heterodimer had a powerful effect on cholesterol homeostasis by inducing the expression of ABC transporters (specifically, ABCA1) in enterocytes. This increase in ABCA1 expression represented the second mechanism by which the administration of the RXR ligand decreased cholesterol absorption.
| Novel Role for ABC Transporters in Intestinal Sterol Absorption. |
|---|
|
|
|---|
On the basis of the recent ABC transporter findings, Mangelsdorf and
colleagues (6)
hypothesized that ABCA1 may be
involved in regulating the absorption of dietary cholesterol. Perhaps
ABCA1 normally pumps cholesterol from enterocytes back out to the
intestinal lumen, thereby limiting the amount of cholesterol absorbed.
Indeed, they found that mice treated with the RXR ligand had increased
intestinal expression of ABCA1, an increase that was mediated by the
activation of the LXR-RXR heterodimer. Therefore, by increasing the
expression of ABCA1 in the small intestine, the LXR-RXR heterodimer
enhanced the efflux of cholesterol from enterocytes and limited
cholesterol absorption. Given these findings, pharmacological
activation of the nuclear hormone receptors RXR, LXR and FXR may
represent a new treatment option for hypercholesterolemia in the
future.
| ABC Transporters: Defense against Excess Sterol Absorption. |
|---|
|
|
|---|
This defense against the absorption of plant sterols is disrupted in
sitosterolemia, a rare autosomal recessive disorder characterized by
the accumulation of large amounts of plant sterols in most tissues
(13)
. Sitosterolemia patients also have increased
absorption of dietary cholesterol and elevated plasma cholesterol
levels. As a result, almost all patients develop coronary artery
disease at an early age. The genetic defect was localized to chromosome
2p21 in 1998 (14)
, and recently two groups independently
identified the gene as a member of the ABC transporter family
(15
,16)
.
One of these groups, Hobbs and colleagues (15)
, was
aided by the observation that activation of the LXR-RXR heterodimer
increased the expression of ABCA1 in the small intestine and enhanced
the efflux of cholesterol from enterocytes (6)
.
They therefore hypothesized that the gene involved in sitosterolemia
may be a transporter protein and that the expression of this
transporter may be induced by a LXR agonist. Thus, the investigators
used DNA microarrays to search for genes that had increased expression
in response to a synthetic LXR ligand.
One such gene, ABCG5, mapped to chromosome 2p21 and encoded a half-ABC transporter. Adjacent to ABCG5 was another half-ABC transporter gene (ABCG8). These two genes were similarly regulated. For example, both ABCG5 and ABCG8 were expressed in the small intestine and the liver and induced by a high cholesterol diet in mice. Available evidence suggests that these two half-transporters unite to form a full, active transporter. When functioning, this transporter may limit the absorption of both plant sterols and cholesterol by actively pumping them from enterocytes back into the intestinal lumen. The transporter may also promote the elimination of sterols in the liver by enhancing their excretion into bile. As a result, mutations in either gene could cause sitosterolemia. Indeed, mutations in ABCG8 most likely accounted for the disease in four of the nine families studied. Additional studies, including gene knockout experiments in animals, will be required to confirm and further elucidate the in vivo functions of these newly identified ABC transporters in cholesterol metabolism.
| Role of Cholesterol Ester Synthesis in Diet-Induced Hypercholesterolemia: Lessons from Mice Lacking Intestinal ACAT. |
|---|
|
|
|---|
|
This protection from diet-induced hypercholesterolemia and gallstone formation in ACAT2-deficient mice resulted from a decreased ability to absorb dietary cholesterol. When fed the high fat, high cholesterol diet, cholesterol absorption in ACAT2-deficient mice was 85% lower than in wild-type mice. These results indicate that under low dietary cholesterol conditions, cholesterol esterification was not required for efficient absorption. When dietary cholesterol content increased, however, the deficiency of cholesterol esterification activity limited the capacity for dietary cholesterol absorption. Given the high cholesterol content of the typical Western diet, inhibition of cholesterol esterification in the intestine may prove to be an effective means to prevent diet-induced hypercholesterolemia.
In summary, the tools of molecular biology and genetics have advanced
the field of sterol absorption significantly. Recent studies have
identified several new molecules and pathways that are involved in
sterol absorption (Fig. 3
). In addition to elucidating some of the molecular mechanisms of sterol
absorption, these findings may offer new therapeutic options to treat
hypercholesterolemia.
|
| ACKNOWLEDGMENTS |
|---|
| FOOTNOTES |
|---|
2 Abbreviations used: ABC, ATP-binding
cassette; ACAT, acyl CoA:cholesterol acyltransferase; CYP7A1,
cholesterol 7
-hydroxylase; FXR, farnesoid X receptor; LXR, liver X
receptor; RXR, retinoid X receptor. ![]()
| LITERATURE CITED |
|---|
|
|
|---|
1. Ros E. (2000) Intestinal absorption of triglyceride and cholesterol. Dietary and pharmacological inhibition to reduce cardiovascular risk. Atherosclerosis 151:357-379.
2. Repa J. J. & Mangelsdorf D. J. (1999) Nuclear receptor regulation of cholesterol and bile acid metabolism. Curr. Opin. Biotechnol. 10:557-563.[Medline]
3. Russell D. W. (1999) Nuclear orphan receptors control cholesterol catabolism. Cell 97:539-542.[Medline]
4. Accad M. & Farese R. V., Jr (1998) Cholesterol homeostasis: a role for oxysterols. Curr. Biol. 8:R601-R604.[Medline]
5. Lu T. T., Makishima M., Repa J. J., Schoonjans K., Kerr T. A., Auwerx J. & Mangelsdorf D. J. (2000) Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors. Mol. Cell 6:507-515.[Medline]
6.
Repa J. J., Turley S. D., Lobaccaro J.-M.A., Medina J., Li L., Lustig K., Shan B., Heyman R. A., Dietschy J. M. & Mangelsdorf D. J. (2000) Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers. Science (Washington DC) 289:1524-1529.
7.
Allayee H., Laffitte B. A. & Lusis A. J. (2000) An absorbing study of cholesterol. Science (Washington DC) 290:1709-1711.
8. Brooks-Wilson A., Marcil M., Clee S. M., Zhang L.-H., Roomp K., van Dam M., Yu L., Brewer C., Collins J. A., Molhuizen H.O.F., Loubser O., Ouelette B.F.F., Fichter K., Ashbourne-Excoffon K.J.D., Sensen C. W., Scherer S., Mott S., Denis M., Martindale D., Frohlich J., Morgan K., Koop B., Pimstone S., Kastelein J.J.P., Genest J. & Hayden M. R. (1999) Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency. Nat. Genet. 22:336-345.[Medline]
9. Orsó E., Broccardo C., Kaminski W. E., Böttcher A., Liebisch G., Drobnik W., Götz A., Chambenoit O., Diederich W., Langmann T., Spruss T., Luciani M.-F., Rothe G., Lackner K. J., Chimini G. & Schmitz G. (2000) Transport of lipids from Golgi to plasma membrane is defective in Tangier disease patients and Abc1-deficient mice. Nat. Genet. 24:192-196.[Medline]
10. Wilson M. D. & Rudel L. L. (1994) Review of cholesterol absorption with emphasis on dietary and biliary cholesterol. J. Lipid Res. 35:943-955.[Medline]
11. Dawson P. A. & Rudel L. L. (1999) Intestinal cholesterol absorption. Curr. Opin. Lipidol. 10:315-320.[Medline]
12. Salen G., Ahrens E. H., Jr & Grundy S. M. (1970) Metabolism of ß-sitosterol in man. J. Clin. Investig. 49:952-967.
13. Bhattacharyya A. K. & Connor W. E. (1974) Beta-sitosterolemia and xanthomatosis. A newly described lipid storage disease in two sisters. J. Clin. Investig. 53:1033-1043.
14. Patel S. B., Salen G., Hidaka H., Kwiterovich P. O., Jr, Stalenhoef A. F. H., Miettinen T. A., Grundy S. M., Lee M.-H., Rubenstein J. S., Polymeropoulos M. H. & Brownstein M. J. (1998) Mapping a gene involved in regulating dietary cholesterol absorption. The sitosterolemia locus is found at chromosome 2p21. J. Clin. Investig. 102:1041-1044.
15.
Berge K. E., Tian H., Graf G. A., Yu L., Grishin N. V., Schultz J., Kwiterovich P., Shan B., Barnes R. & Hobbs H. H. (2000) Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters. Science (Washington DC) 290:1771-1775.
16. Lee M.-H., Lu K., Hazard S., Yu H., Shulenin S., Hidaka H., Kojima H., Allikmets R., Sakuma N., Pegoraro R., Srivastava A. K., Salen G., Dean M. & Patel S. B. (2001) Identification of a gene, ABCG5, important in the regulation of dietary cholesterol absorption. Nat. Genet. 27:79-83.[Medline]
17. Chang T. Y., Chang C.C.Y. & Cheng D. (1997) Acyl-coenzyme A:cholesterol acyltransferase. Annu. Rev. Biochem. 66:613-638.[Medline]
18. Meiner V., Tam C., Gunn M. D., Dong L. M., Weisgraber K. H., Novak S., Myers H. M., Erickson S. K. & Farese R. V., Jr (1997) Tissue expression studies of mouse acyl CoA:cholesterol acyltransferase gene (Acact): findings supporting the existence of multiple cholesterol esterification enzymes in mice. J. Lipid Res. 38:1928-1933.[Abstract]
19.
Cases S., Novak S., Zheng Y. W., Myers H. M., Lear S. R., Sande E., Welch C. B., Lusis A. J., Krause B. R., Erickson S. K. & Farese R. V., Jr. (1998) ACAT-2, a second mammalian acyl-coA:cholesterol acyltransferase. Its cloning, expression, and characterization. J. Biol. Chem. 273:26755-26764.
20. Buhman K. K., Accad M., Novak S., Choi R. S., Wong J. S., Hamilton R. L., Turley S. & Farese R. V., Jr (2000) Resistance to diet-induced hypercholesterolemia and gallstone formation in ACAT2-deficient mice. Nat. Med. 6:1341-1347.[Medline]
This article has been cited by other articles:
![]() |
H. Tomoyori, Y. Kawata, T. Higuchi, I. Ichi, H. Sato, M. Sato, I. Ikeda, and K. Imaizumi Phytosterol Oxidation Products Are Absorbed in the Intestinal Lymphatics in Rats but Do Not Accelerate Atherosclerosis in Apolipoprotein E-Deficient Mice J. Nutr., July 1, 2004; 134(7): 1690 - 1696. [Abstract] [Full Text] |
||||
![]() |
J. Quilez, M. Rafecas, G. Brufau, P. Garcia-Lorda, I. Megias, M. Bullo, J. A. Ruiz, and J. Salas-Salvado Bakery Products Enriched with Phytosterol Esters, {alpha}-Tocopherol and {beta}-Carotene Decrease Plasma LDL-Cholesterol and Maintain Plasma {beta}-Carotene Concentrations in Normocholesterolemic Men and Women J. Nutr., October 1, 2003; 133(10): 3103 - 3109. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Naumann, J. Plat, and R. P. Mensink Changes in Serum Concentrations of Noncholesterol Sterols and Lipoproteins in Healthy Subjects Do Not Depend on the Ratio of Plant Sterols to Stanols in the Diet J. Nutr., September 1, 2003; 133(9): 2741 - 2747. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Igel, U. Giesa, D. Lutjohann, and K. von Bergmann Comparison of the intestinal uptake of cholesterol, plant sterols, and stanols in mice J. Lipid Res., March 1, 2003; 44(3): 533 - 538. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Aprikian, J. Busserolles, C. Manach, A. Mazur, C. Morand, M.-J. Davicco, C. Besson, Y. Rayssiguier, C. Remesy, and C. Demigne Lyophilized Apple Counteracts the Development of Hypercholesterolemia, Oxidative Stress, and Renal Dysfunction in Obese Zucker Rats J. Nutr., July 1, 2002; 132(7): 1969 - 1976. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||